Dr. B has raised $8 million in seed funding for its newly launched telehealth prescription service now accessible in 41 states. The corporate is called after CEO and Founder Cyrus Massoumi’s grandfather, who was nicknamed Dr. Bubba and have become a physician in the course of the 1918 Spanish flu.
Based on the top of Covid-19 in 2021, New York Metropolis-based Dr. B began as a web-based enterprise that matched folks with unused vaccines. It was in a position to provide vaccines to greater than 1 million folks in 37 states by partnering with greater than 700 healthcare suppliers, in line with a information launch. Now as vaccines are extra available, the corporate is switching gears. It now goals to enhance the restricted entry to at-home Covid-19 therapies, beginning with Paxlovid and molnupiravir.
“Whereas Covid-19 antiviral drugs have been accessible for a number of months and there’s a lot of demand, many individuals nonetheless have a tough time accessing them as a result of they require a prescription,” Massoumi stated. “Sufferers want versatile choices for getting that prescription, which is why we began by offering Covid-19 antiviral prescriptions.”
Though the corporate is beginning with these prescriptions, the funding will assist it broaden to different therapies past Covid-19, Massoumi stated. This contains therapies for coronary heart well being, dermatology and reproductive care. The startup may even work to supply its service in languages aside from Spanish and English, he added.
To obtain prescription drugs, Dr. B sufferers fill out a web-based evaluation by its web site. They need to submit a photograph of a optimistic Covid-19 check and reply questions on signs, pre-existing situations and drugs they’re presently taking. Then a board-certified physician critiques the responses and if the doctor finds the affected person is eligible, a prescription is shipped to the affected person’s pharmacy of alternative.
“We remedy a key ache level within the course of — the necessity to get a physician prescription inside 5 days of testing optimistic,” Massoumi stated. “Our platform provides a hassle-free technique to get prescriptions on-line, with out the necessity for an appointment.”
The corporate is concentrated on offering low-cost — or generally no-cost — care to sufferers, stated Massoumi, who beforehand based Zocdoc, a web-based service that permits folks to seek out and guide medical appointments.
“I’m happy with the work we completed whereas I used to be at Zocdoc, however one in all my greatest regrets is that we didn’t do sufficient to enhance entry to healthcare for everybody,” he stated. “I’m making an attempt to right that with Dr. B.”
Most sufferers pay a $15 session charge. However individuals who want it will possibly obtain the providers without spending a dime, so long as they qualify. These sufferers need to fill out a questionnaire about their month-to-month earnings to find out in the event that they’re eligible.
Massoumi added that whereas the charge “is lower than the common insurance coverage copay” it nonetheless helps Dr. B to offer “no-cost take care of lower-income sufferers.”
Different on-line prescription corporations embrace GeniusRx and Amazon Pharmacy, however Massoumi stated Dr. B differs from rivals by offering this no-cost choice.
Picture: Stuart Ritchie, Getty Photos